UNSPSC 51201646: Measles and rubella virus vaccine

This clasification denotes a compound vaccine. The first disease that this compound vaccine prevents is a highly contagious infectious disease caused by morbillivirus, called measles, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the mononuclear phagocyte system.

The second disease this compound vaccine prevents is an acute infectious disease caused by the rubella virus, commonly called rubella, and which enters the respiratory tract via airborne droplet and spreads to the lymphatic system.

UNSPSC 51201646 Measles and rubella virus vaccine, a Commodity code, encompasses vaccine procurement by state and local health agencies. The recent activity under this code does not align with its nominal scope — the single posted opportunity involves yellow fever vaccine rather than measles and rubella formulations, suggesting either a coding error in the state procurement system or broader vaccine commodity classification that may not cleanly separate by pathogen. State and local health departments use this code to procure immunization products, typically through sole source or limited-source notices when specific manufacturers or formulations are required to meet public health protocol or supply agreements.

The Mississippi State Department of Health posted a sole source procurement notice on July 13, 2026 for yellow fever vaccine from Sanofi Pasteur, Inc., with an objections deadline of August 3, 2026 at 10:00 a.m. CST. The notice provided no quantity, contract term, or estimated value. The source record shows minimal recent activity under this code; the single entry represents state-level health procurement rather than county, municipal, or school district activity. Geographic concentration in the recent record is insufficient to characterize — the Mississippi example stands alone without supporting data from other states or jurisdictions. Interested vendors should monitor state health department procurement channels in their target markets, as vaccine purchases often move through sole source or cooperative purchasing vehicles with short objection or response windows rather than competitive RFP cycles.